Stay updated on Dupilumab in ABPA Treatment Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in ABPA Treatment Clinical Trial page.

Latest updates to the Dupilumab in ABPA Treatment Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision updated to v3.5.0; previous revision v3.4.3 was removed.SummaryDifference0.0%

- Check24 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No visible changes to the study details or page layout.SummaryDifference0.0%

- Check53 days agoChange DetectedNew revision label 'Revision: v3.4.2' appears, replacing 'Revision: v3.4.1', indicating a minor site update that does not change study details.SummaryDifference0.0%

- Check60 days agoChange DetectedA minor update shows the page revision label changing from v3.4.0 to v3.4.1 (the addition of Revision: v3.4.1 and removal of Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page now shows a 'Show glossary' option and a QC-related 'Last Update Submitted that Met QC Criteria' label, and the footer includes 'No FEAR Act Data' and 'Revision: v3.4.0' replacing earlier text. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedMinor revision label updated from v3.3.3 to v3.3.4 on the page, with no changes to study content, enrollment, outcomes, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in ABPA Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in ABPA Treatment Clinical Trial page.